Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
Brain
    August 2021
  1. NAUGHTON M, de la Fuente AG
    Autoantibodies and microglia: boon or bane?
    Brain. 2021 Aug 11. pii: 6348165. doi: 10.1093.
    >> Share

    July 2021
  2. MITSDOERFFER M, Di Liberto G, Dotsch S, Sie C, et al
    Corrigendum to: Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity.
    Brain. 2021 Jul 14. pii: 6321151. doi: 10.1093.
    >> Share

    June 2021
  3. BITTNER S, Oh J, Havrdova EK, Tintore M, et al
    The potential of serum neurofilament as biomarker for multiple sclerosis.
    Brain. 2021 Jun 28. pii: 6310737. doi: 10.1093.
    >> Share

  4. PELLERIN K, Rubino SJ, Burns JC, Smith BA, et al
    MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response.
    Brain. 2021 Jun 18. pii: 6305830. doi: 10.1093.
    >> Share

    May 2021
  5. GRANZIERA C, Wuerfel J, Barkhof F, Calabrese M, et al
    Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
    Brain. 2021 May 10. pii: 6273092. doi: 10.1093.
    >> Share

  6. VAN DOORN PA, Hadden RDM, Van den Bergh PYK
    Elucidating autoimmune nodopathies and the CIDP spectrum.
    Brain. 2021;144:1043-1045.
    >> Share

    April 2021
  7. FLECK AK, Hucke S, Teipel F, Eschborn M, et al
    Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity.
    Brain. 2021 Apr 26. pii: 6252379. doi: 10.1093.
    >> Share

  8. GHORBANI S, Yong VW
    The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis.
    Brain. 2021 Apr 23. pii: 6247173. doi: 10.1093.
    >> Share

  9. PARDINI M, Brown JWL, Magliozzi R, Reynolds R, et al
    Surface-in pathology in multiple sclerosis: a new view on pathogenesis?
    Brain. 2021 Apr 20. pii: 6238675. doi: 10.1093.
    >> Share

  10. PISA M, Croese T, Dalla Costa G, Guerrieri S, et al
    Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes.
    Brain. 2021 Apr 8. pii: 6215108. doi: 10.1093.
    >> Share

  11. LUCCHESE G, Floel A
    Guillain-Barre syndrome, SARS-CoV-2 and molecular mimicry.
    Brain. 2021 Apr 3. pii: 6209729. doi: 10.1093.
    >> Share

  12. LUNN MP, Carr AC, Keddie S, Pakpoor J, et al
    Reply: Guillain-Barre syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barre syndrome and Unclear association between COVID-19 and Guillain-Barre syndrome and Currently avai
    Brain. 2021 Apr 3. pii: 6209732. doi: 10.1093.
    >> Share

  13. FOSCHI M, D'Anna L, Abdelhak A, Mayer B, et al
    Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2021 Apr 3. pii: 6209733. doi: 10.1093.
    >> Share

  14. GONZALEZ DEL CASTILLO J, Porta-Etessam J, Miro O
    Currently available data regarding the potential association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2021 Apr 3. pii: 6209731. doi: 10.1093.
    >> Share

    March 2021
  15. ONTANEDA D, Raza PC, Mahajan KR, Arnold DL, et al
    Deep grey matter injury in multiple sclerosis: A NAIMS consensus statement.
    Brain. 2021 Mar 23. pii: 6184142. doi: 10.1093.
    >> Share

  16. VOGRIG A, Moritz CP, Camdessanche JP, Tholance Y, et al
    Unclear association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2021 Mar 23. pii: 6181752. doi: 10.1093.
    >> Share

  17. BHARGAVA P, Kim S, Reyes AA, Grenningloh R, et al
    Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition.
    Brain. 2021 Mar 16. pii: 6173632. doi: 10.1093.
    >> Share

  18. SABEL CE, Pearson JF, Mason DF, Willoughby E, et al
    The latitude gradient for multiple sclerosis prevalence is established in the early lifecourse.
    Brain. 2021 Mar 11. pii: 6168130. doi: 10.1093.
    >> Share

  19. RAHMANZADEH R, Lu PJ, Barakovic M, Weigel M, et al
    Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
    Brain. 2021 Mar 9. pii: 6164965. doi: 10.1093.
    >> Share

  20. MITSDORFFER M, Di Liberto G, Dotsch S, Sie C, et al
    Formation and immunomodulatory function of meningeal B-cell aggregates in progressive CNS autoimmunity.
    Brain. 2021 Mar 9. pii: 6164962. doi: 10.1093.
    >> Share

  21. XU Y, Smith KA, Hiyoshi A, Piehl F, et al
    Hospital-diagnosed infections before age 20 and risk of a subsequent multiple sclerosis diagnosis.
    Brain. 2021 Mar 9. pii: 6164964. doi: 10.1093.
    >> Share

    February 2021
  22. KILPATRICK TJ, Binder MD
    Neuregulin therapy for multiple sclerosis: an each-way bet?
    Brain. 2021;144:6-8.
    >> Share

    January 2021
  23. DAL-BIANCO A, Grabner G, Kronnerwetter C, Weber M, et al
    Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI.
    Brain. 2021 Jan 23. pii: 6114694. doi: 10.1093.
    >> Share


  24. Corrigendum to: Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Brain. 2021 Jan 11. pii: 6082765. doi: 10.1093.
    >> Share

    December 2020
  25. KIM K, Probstel AK, Baumann R, Dyckow J, et al
    Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.
    Brain. 2020 Dec 29. pii: 6055080. doi: 10.1093.
    >> Share

  26. HALDER SK, Milner R
    Hypoxia in multiple sclerosis; is it the chicken or the egg?
    Brain. 2020 Dec 22. pii: 6044083. doi: 10.1093.
    >> Share

  27. LUNN MP, Cornblath DR, Jacobs BC, Querol L, et al
    COVID-19 vaccine and Guillain-Barre syndrome: let's not leap to associations.
    Brain. 2020 Dec 14. pii: 6031904. doi: 10.1093.
    >> Share

  28. KEDDIE S, Pakpoor J, Mousele C, Pipis M, et al
    Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2020 Dec 14. pii: 6031905. doi: 10.1093.
    >> Share

  29. KATARIA H, Hart CG, Alizadeh A, Cossoy M, et al
    Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis.
    Brain. 2020 Dec 13. pii: 6032483. doi: 10.1093.
    >> Share

  30. HOHLFELD R, Beltran E, Gerdes LA, Dornmair K, et al
    Tissue-resident CD8+ memory T cells in multiple sclerosis.
    Brain. 2020 Dec 13. pii: 6032479. doi: 10.1093.
    >> Share

  31. SMOLDERS J, Fransen NL, Huitinga I, Hamann J, et al
    Reply: Tissue-resident CD8+ memory T cells in multiple sclerosis.
    Brain. 2020 Dec 13. pii: 6032480. doi: 10.1093.
    >> Share

  32. EFTIMOV F, Lucke IM, Querol LA, Rajabally YA, et al
    Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy.
    Brain. 2020;143:3214-3224.
    >> Share

  33. PATERSON RW, Brown RL, Vivekanandam V, Foulkes AJM, et al
    Reply: Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe?
    Brain. 2020;143:e101.
    >> Share

  34. KARAPANAYIOTIDES T, Geka E, Prassopoulos P, Koutroulou I, et al
    Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe?
    Brain. 2020;143:e100.
    >> Share

  35. CAO A, Rohaut B, Le Guennec L, Saheb S, et al
    Severe COVID-19-related encephalitis can respond to immunotherapy.
    Brain. 2020;143:e102.
    >> Share

    November 2020
  36. PETROU P, Kassis I, Levin N, Paul F, et al
    Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
    Brain. 2020 Nov 30. pii: 6012789. doi: 10.1093.
    >> Share

  37. PETZOLD A, Chua SYL, Khawaja AP, Keane PA, et al
    Retinal asymmetry in multiple sclerosis.
    Brain. 2020 Nov 30. pii: 6012795. doi: 10.1093.
    >> Share

  38. SCHIAVI S, Petracca M, Sun P, Fleysher L, et al
    Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis.
    Brain. 2020 Nov 30. pii: 5999115. doi: 10.1093.
    >> Share

  39. STERIADE C, Titulaer MJ, Vezzani A, Sander JW, et al
    The association between systemic autoimmune disorders and epilepsy and its clinical implications.
    Brain. 2020 Nov 22. pii: 5998333. doi: 10.1093.
    >> Share

  40. DE MEO E, Storelli L, Moiola L, Ghezzi A, et al
    In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology.
    Brain. 2020 Nov 21. pii: 5998271. doi: 10.1093.
    >> Share

  41. MARIANO R, Messina S, Roca-Fernandez A, Leite MI, et al
    Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Brain. 2020 Nov 18. pii: 5989776. doi: 10.1093.
    >> Share

  42. ELLENBERGER D, Flachenecker P, Fneish F, Frahm N, et al
    Aggressive multiple sclerosis - a matter of measurement and timing.
    Brain. 2020 Nov 11. pii: 5974108. doi: 10.1093.
    >> Share

  43. KALINCIK T, Malpas CB
    Reply: Aggressive multiple sclerosis - a matter of measurement and timing.
    Brain. 2020 Nov 11. pii: 5974107. doi: 10.1093.
    >> Share

    October 2020
  44. SUCKSDORFF M, Matilainen M, Tuisku J, Polvinen E, et al
    Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Brain. 2020 Oct 2. pii: 5917253. doi: 10.1093.
    >> Share

  45. GAUDIOSO C, Naismith RT
    Optimizing treatment strategies in paediatric, adult and late-onset multiple sclerosis.
    Brain. 2020;143:2866-2868.
    >> Share

    September 2020
  46. AMATO MP, Fonderico M, Portaccio E, Pasto L, et al
    Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
    Brain. 2020 Sep 16. pii: 5906150. doi: 10.1093.
    >> Share

  47. OUELLETTE R, Treaba CA, Granberg T, Herranz E, et al
    7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
    Brain. 2020 Sep 16. pii: 5906152. doi: 10.1093.
    >> Share

  48. WAGNON I, Helie P, Bardou I, Regnauld C, et al
    Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor.
    Brain. 2020 Sep 7. pii: 5902131. doi: 10.1093.
    >> Share

  49. GERALDES R, Esiri MM, Perera R, Yee SA, et al
    Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships.
    Brain. 2020 Sep 2. pii: 5900415. doi: 10.1093.
    >> Share

  50. ROOS I, Leray E, Frascoli F, Casey R, et al
    Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
    Brain. 2020;143:2742-2756.
    >> Share

  51. KULLMANN DM
    Editorial.
    Brain. 2020;143:2625.
    >> Share

  52. RICHARD C, Ruiz A, Cavagna S, Bigotte M, et al
    Connexins in neuromyelitis optica: a link between astrocytopathy and demyelination.
    Brain. 2020;143:2721-2732.
    >> Share

  53. MANNARA F, Radosevic M, Planaguma J, Soto D, et al
    Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
    Brain. 2020;143:2709-2720.
    >> Share

    August 2020
  54. BOUMAN PM, Steenwijk MD, Pouwels PJW, Schoonheim MM, et al
    Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis.
    Brain. 2020 Aug 21. pii: 5895168. doi: 10.1093.
    >> Share

  55. CHITNIS T, Aaen G, Belman A, Benson L, et al
    Improved relapse recovery in paediatric compared to adult multiple sclerosis.
    Brain. 2020 Aug 18. pii: 5894047. doi: 10.1093.
    >> Share

    July 2020
  56. SORENSEN PS, Sellebjerg F, Hartung HP, Montalban X, et al
    The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
    Brain. 2020 Jul 24. pii: 5876125. doi: 10.1093.
    >> Share

    June 2020
  57. JACKLE K, Zeis T, Schaeren-Wiemers N, Junker A, et al
    Molecular signature of slowly expanding lesions in progressive multiple sclerosis.
    Brain. 2020 Jun 24. pii: 5861738. doi: 10.1093.
    >> Share

  58. KERBRAT A, Gros C, Badji A, Bannier E, et al
    Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.
    Brain. 2020 Jun 23. pii: 5861019. doi: 10.1093.
    >> Share

  59. ZEKERIDOU A, Pittock SJ
    Synaptic autoimmunity: new insights into LGI1 antibody-mediated neuronal dysfunction.
    Brain. 2020;143:1622-1625.
    >> Share

    May 2020
  60. RAMBERGER M, Berretta A, Tan JMM, Sun B, et al
    Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
    Brain. 2020 May 21. pii: 5841730. doi: 10.1093.
    >> Share

  61. FRANSEN NL, Hsiao CC, van der Poel M, Engelenburg HJ, et al
    Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
    Brain. 2020 May 13. pii: 5836675. doi: 10.1093.
    >> Share

  62. MALPAS CB, Manouchehrinia A, Sharmin S, Roos I, et al
    Early clinical markers of aggressive multiple sclerosis.
    Brain. 2020 May 9. pii: 5835340. doi: 10.1093.
    >> Share

  63. KADOWAKI A, Quintana FJ
    The NLRP3 inflammasome in progressive multiple sclerosis.
    Brain. 2020;143:1286-1288.
    >> Share

  64. TAKAI Y, Misu T, Kaneko K, Chihara N, et al
    Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
    Brain. 2020;143:1431-1446.
    >> Share

    April 2020
  65. DIETRICH M, Koska V, Hecker C, Gottle P, et al
    Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
    Brain. 2020 Apr 15. pii: 5820386. doi: 10.1093.
    >> Share

  66. MALHOTRA S, Costa C, Eixarch H, Keller CW, et al
    NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
    Brain. 2020 Apr 13. pii: 5819591. doi: 10.1093.
    >> Share

    March 2020
  67. KLEEREKOOPER I, Petzold A, Trip SA
    Anterior visual system imaging to investigate energy failure in multiple sclerosis.
    Brain. 2020 Mar 12. pii: 5804129. doi: 10.1093.
    >> Share

    January 2020
  68. ROWE J
    Editorial.
    Brain. 2020;143:1.
    >> Share

    November 2019
  69. MEIJER KA, Steenwijk MD, Douw L, Schoonheim MM, et al
    Long-range connections are more severely damaged and relevant for cognition in multiple sclerosis.
    Brain. 2019 Nov 15. pii: 5626204. doi: 10.1093.
    >> Share

    October 2019
  70. HAUSLER D, Torke S, Peelen E, Bertsch T, et al
    Reply: Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis.
    Brain. 2019 Oct 30. pii: 5610115. doi: 10.1093.
    >> Share

  71. SMOLDERS J, Damoiseaux J, Hupperts R
    Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis.
    Brain. 2019 Oct 30. pii: 5610116. doi: 10.1093.
    >> Share

  72. SABBAGH S, Almeida de Jesus A, Hwang S, Kuehn HS, et al
    Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.
    Brain. 2019 Oct 11. pii: 5585662. doi: 10.1093.
    >> Share

  73. LANDON-CARDINAL O, Benveniste O, Allenbach Y
    Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.
    Brain. 2019 Oct 11. pii: 5585663. doi: 10.1093.
    >> Share

  74. CRISP SJ, Dixon CL, Jacobson L, Chabrol E, et al
    Glycine receptor autoantibodies disrupt inhibitory neurotransmission.
    Brain. 2019 Oct 8. pii: 5583666. doi: 10.1093.
    >> Share

  75. NUTMA E, Stephenson JA, Gorter RP, de Bruin J, et al
    A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Brain. 2019 Oct 3. pii: 5580333. doi: 10.1093.
    >> Share

  76. KARAKAYA M, Wirth B
    Hereditary nodo-paranodopathies: genomic variants, not just autoantibodies, hit the protein.
    Brain. 2019;142:2895-2897.
    >> Share

    September 2019
  77. ELLIOTT C, Belachew S, Wolinsky JS, Hauser SL, et al
    Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Brain. 2019;142:2787-2799.
    >> Share

  78. PENNER IK, Hartung HP
    The dark side of the moon: looking beyond beneficial effects of cannabis use in multiple sclerosis.
    Brain. 2019;142:2552-2555.
    >> Share

  79. BENVENISTE O, Allenbach Y
    Inclusion body myositis: accumulation of evidence for its autoimmune origin.
    Brain. 2019;142:2549-2551.
    >> Share

    August 2019
  80. MORQUETTE B, Juzwik CA, Drake SS, Charabati M, et al
    MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis.
    Brain. 2019 Aug 14. pii: 5549993. doi: 10.1093.
    >> Share

  81. BROWNLEE WJ, Altmann DR, Prados F, Miszkiel KA, et al
    Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brain. 2019;142:2276-2287.
    >> Share

    July 2019
  82. FEINSTEIN A, Meza C, Stefan C, Staines RW, et al
    Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
    Brain. 2019 Jul 30. pii: 5541023. doi: 10.1093.
    >> Share

  83. WENTLING M, Lopez-Gomez C, Park HJ, Amatruda M, et al
    A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis.
    Brain. 2019 Jul 15. pii: 5531715. doi: 10.1093.
    >> Share

  84. HAUSLER D, Torke S, Peelen E, Bertsch T, et al
    High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium.
    Brain. 2019 Jul 13. pii: 5532100. doi: 10.1093.
    >> Share

  85. FITZGERALD KC, Kim K, Smith MD, Aston SA, et al
    Early complement genes are associated with visual system degeneration in multiple sclerosis.
    Brain. 2019 Jul 9. pii: 5530228. doi: 10.1093.
    >> Share

  86. ROPELE S, Fazekas F
    Quantification of cortical damage in multiple sclerosis using DTI remains a challenge.
    Brain. 2019;142:1848-1850.
    >> Share

    June 2019
  87. FILIPPI M, Preziosa P, Banwell BL, Barkhof F, et al
    Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
    Brain. 2019 Jun 17. pii: 5519813. doi: 10.1093.
    >> Share

  88. PREZIOSA P, Kiljan S, Steenwijk MD, Meani A, et al
    Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex.
    Brain. 2019 Jun 5. pii: 5511700. doi: 10.1093.
    >> Share

    May 2019
  89. MUNK NIELSEN N, Corn G, Frisch M, Stenager E, et al
    Multiple sclerosis among first- and second-generation immigrants in Denmark: a population-based cohort study.
    Brain. 2019 May 13. pii: 5488579. doi: 10.1093.
    >> Share

  90. COTZOMI E, Stathopoulos P, Lee CS, Ritchie AM, et al
    Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.
    Brain. 2019 May 5. pii: 5485817. doi: 10.1093.
    >> Share

  91. GIOVANNONI G
    Survival: the ultimate long-term outcome in multiple sclerosis.
    Brain. 2019;142:1166-1167.
    >> Share

  92. PALACE J, Lin DY, Zeng D, Majed M, et al
    Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.
    Brain. 2019;142:1310-1323.
    >> Share

    April 2019
  93. VAN COEVORDEN-HAMEETE MH, de Bruijn MAAM, de Graaff E, Bastiaansen DAEM, et al
    The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.
    Brain. 2019 Apr 22. pii: 5476117. doi: 10.1093.
    >> Share

  94. WEKERLE H
    Secondary progressive multiple sclerosis and the gut-brain axis.
    Brain. 2019;142:838-840.
    >> Share

    March 2019
  95. KINGWELL E, Leray E, Zhu F, Petkau J, et al
    Multiple sclerosis: effect of beta interferon treatment on survival.
    Brain. 2019 Mar 18. pii: 5382233. doi: 10.1093.
    >> Share

  96. HOHLFELD R
    Immune dysbalance in childhood multiple sclerosis: a 'chicken or the egg' conundrum.
    Brain. 2019;142:490-492.
    >> Share

    February 2019
  97. KADOWAKI A, Saga R, Lin Y, Sato W, et al
    Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
    Brain. 2019 Feb 15. pii: 5321131. doi: 10.1093.
    >> Share

  98. MEXHITAJ I, Nyirenda MH, Li R, O'Mahony J, et al
    Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.
    Brain. 2019 Feb 12. pii: 5316384. doi: 10.1093.
    >> Share

  99. ALLENBACH Y, Bolko L, Toquet S, Landon-Cardinal O, et al
    Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.
    Brain. 2019 Feb 1. pii: 5305679. doi: 10.1093.
    >> Share

  100. PAPADOPOULOU C, Hong Y, Omoyinmi E, Brogan PA, et al
    Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.
    Brain. 2019 Feb 1. pii: 5305681. doi: 10.1093.
    >> Share

    January 2019
  101. EDEN D, Gros C, Badji A, Dupont SM, et al
    Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Brain. 2019 Jan 30. pii: 5304670. doi: 10.1093.
    >> Share

  102. NTRANOS A, Ntranos V, Bonnefil V, Liu J, et al
    Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis.
    Brain. 2019 Jan 28. pii: 5303708. doi: 10.1093.
    >> Share

  103. CHEN Y, Podojil JR, Kunjamma RB, Jones J, et al
    Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.
    Brain. 2019 Jan 17. pii: 5289373. doi: 10.1093.
    >> Share

    December 2018
  104. VON ESSEN MR, Ammitzboll C, Hansen RH, Petersen ERS, et al
    Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
    Brain. 2018 Dec 17. pii: 5250831. doi: 10.1093.
    >> Share

  105. KAUNZNER UW, Kang Y, Zhang S, Morris E, et al
    Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
    Brain. 2018 Dec 15. pii: 5250435. doi: 10.1093.
    >> Share

    November 2018
  106. ZALC B
    One hundred and fifty years ago Charcot reported multiple sclerosis as a new neurological disease.
    Brain. 2018 Nov 20. pii: 5194497. doi: 10.1093.
    >> Share

  107. ALY L, Korn T
    Multiple sclerosis: is it all black and white in optical coherence tomography?
    Brain. 2018;141:3088-3091.
    >> Share

  108. DEBANNE D, El Far O
    Pre- and postsynaptic effects of LGI1 autoantibodies in a murine model of limbic encephalitis.
    Brain. 2018;141:3092-3095.
    >> Share

  109. AESCHLIMANN FA, Fremond ML, Duffy D, Rice GI, et al
    A child with severe juvenile dermatomyositis treated with ruxolitinib.
    Brain. 2018;141:e80.
    >> Share

  110. ALLENBACH Y, Toquet S, Landon-Cardinal O, Benveniste O, et al
    Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib.
    Brain. 2018;141:e81.
    >> Share

    October 2018
  111. CALDITO NG, Saidha S, Sotirchos ES, Dewey BE, et al
    Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.
    Brain. 2018 Oct 11. pii: 5127751. doi: 10.1093.
    >> Share

  112. DOETS AY, Verboon C, van den Berg B, Harbo T, et al
    Regional variation of Guillain-Barre syndrome.
    Brain. 2018;141:2866-2877.
    >> Share

    September 2018
  113. BAKER D, Pryce G, Amor S, Giovannoni G, et al
    Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis.
    Brain. 2018 Sep 12. pii: 5095715. doi: 10.1093.
    >> Share

  114. EIJLERS AJC, van Geest Q, Dekker I, Steenwijk MD, et al
    Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Brain. 2018;141:2605-2618.
    >> Share

    June 2018
  115. MACHADO-SANTOS J, Saji E, Troscher AR, Paunovic M, et al
    The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
    Brain. 2018 Jun 4. pii: 5032773. doi: 10.1093.
    >> Share

  116. STANKOFF B, Louapre C
    Can we use regional grey matter atrophy sequence to stage neurodegeneration in multiple sclerosis?
    Brain. 2018;141:1580-1583.
    >> Share

    May 2018
  117. CAMARA-LEMARROY CR, Metz L, Meddings JB, Sharkey KA, et al
    The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.
    Brain. 2018 May 30. pii: 5025744. doi: 10.1093.
    >> Share

  118. BARRO C, Benkert P, Disanto G, Tsagkas C, et al
    Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Brain. 2018 May 30. pii: 5025690. doi: 10.1093.
    >> Share

  119. ESHAGHI A, Marinescu RV, Young AL, Firth NC, et al
    Progression of regional grey matter atrophy in multiple sclerosis.
    Brain. 2018 May 8. pii: 4993898. doi: 10.1093.
    >> Share

  120. LADISLAU L, Suarez-Calvet X, Toquet S, Landon-Cardinal O, et al
    JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.
    Brain. 2018 May 8. pii: 4993951. doi: 10.1093.
    >> Share

    April 2018
  121. CONRAD BN, Barry RL, Rogers BP, Maki S, et al
    Multiple sclerosis lesions affect intrinsic functional connectivity of the spinal cord.
    Brain. 2018 Apr 10. pii: 4965865. doi: 10.1093.
    >> Share

  122. VAN LANGELAAR J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, et al
    T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.
    Brain. 2018 Apr 5. pii: 4961484. doi: 10.1093.
    >> Share

    March 2018
  123. STEYERBERG EW, Claggett B
    Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919652. doi: 10.1093.
    >> Share

  124. KALINCIK T
    Reply: Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919653. doi: 10.1093.
    >> Share

  125. STEPHENSON EL, Mishra MK, Moussienko D, Laflamme N, et al
    Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
    Brain. 2018 Mar 1. pii: 4915907. doi: 10.1093.
    >> Share

    February 2018
  126. ARRAMBIDE G, Tintore M, Espejo C, Auger C, et al
    The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
    Brain. 2018 Feb 16. pii: 4866204. doi: 10.1093.
    >> Share

    January 2018
  127. SMETS I, Fiddes B, Garcia-Perez JE, He D, et al
    Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.
    Brain. 2018 Jan 18. pii: 4817414. doi: 10.1093.
    >> Share

    December 2017
  128. KIM RY, Mangu D, Hoffman AS, Kovash R, et al
    Oestrogen receptor beta ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis.
    Brain. 2017 Dec 8. pii: 4710057. doi: 10.1093.
    >> Share

    October 2017
  129. GRANBERG T, Fan Q, Treaba CA, Ouellette R, et al
    In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Brain. 2017 Oct 10. doi: 10.1093.
    >> Share

    September 2017
  130. ROCCA MA, Sormani MP, Rovaris M, Caputo D, et al
    Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.
    Brain. 2017 Sep 27. doi: 10.1093.
    >> Share

  131. DATTA G, Colasanti A, Rabiner EA, Gunn RN, et al
    Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Brain. 2017 Sep 23. doi: 10.1093.
    >> Share

  132. KALINCIK T, Manouchehrinia A, Sobisek L, Jokubaitis V, et al
    Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
    Brain. 2017;140:2426-2443.
    >> Share

    July 2017
  133. SCOLDING NJ, Pasquini M, Reingold SC, Cohen JA, et al
    Cell-based therapeutic strategies for multiple sclerosis.
    Brain. 2017 Jul 21. doi: 10.1093.
    >> Share

    May 2017
  134. DELMONT E, Manso C, Querol L, Cortese A, et al
    Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
    Brain. 2017 May 28. doi: 10.1093.
    >> Share

  135. ZRZAVY T, Hametner S, Wimmer I, Butovsky O, et al
    Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
    Brain. 2017 May 24. doi: 10.1093.
    >> Share

  136. HACOHEN Y, Ciccarelli O, Hemingway C
    Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination.
    Brain. 2017;140:1172-1174.
    >> Share

    April 2017
  137. EL BEHI M, Sanson C, Bachelin C, Guillot-Noel L, et al
    Adaptive human immunity drives remyelination in a mouse model of demyelination.
    Brain. 2017;140:967-980.
    >> Share

    March 2017
  138. LONGONI G, Brown RA, MomayyezSiahkal P, Elliott C, et al
    White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Brain. 2017 Mar 14. doi: 10.1093.
    >> Share

  139. JURYNCZYK M, Geraldes R, Probert F, Woodhall MR, et al
    Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
    Brain. 2017;140:617-627.
    >> Share

    February 2017
  140. PONATH G, Ramanan S, Mubarak M, Housley W, et al
    Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.
    Brain. 2017;140.
    >> Share

    June 2016
  141. ARAUJO AQ, Silva MT, Araujo AP
    Zika virus-associated neurological disorders: a review.
    Brain. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016